Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time?
- PMID: 32091922
- DOI: 10.1161/CIRCULATIONAHA.119.044770
Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time?
Keywords: Editorials; coronary artery disease; genome-wide association study; risk assessment.
Comment on
-
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.Circulation. 2020 Feb 25;141(8):624-636. doi: 10.1161/CIRCULATIONAHA.119.044434. Epub 2019 Nov 11. Circulation. 2020. PMID: 31707832 Clinical Trial.
-
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial.Circulation. 2020 Feb 25;141(8):616-623. doi: 10.1161/CIRCULATIONAHA.119.043805. Epub 2019 Nov 11. Circulation. 2020. PMID: 31707849 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical